Identifying clinical and proteomic markers for early diagnosis and prognosis prediction of major psychiatric disorders
Journal of Affective Disorders · 2025-01 · 369 · 886-896
DOI: 10.1016/j.jad.2024.10.054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025-01. Verfasst von Hyunju Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Biomarkers, Bipolar Disorder, Proteomics, Early Diagnosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Korea Ministry of Science and ICT, Ministry of Health and Welfare.
Abstract (Originalsprache)
BACKGROUND: To clarify if blood proteins can predict disease progression among individuals at clinical high-risk of severe mental illness (CHR-SMI), we developed a statistical model incorporating clinical and blood protein markers to distinguish the transition group (who developed severe mental illness) (CHR-SMI-T) and from non-transition group (CHR-SMI-NT) at baseline. METHODS: Ninety individuals (74 at CHR-SMI: 16 patients) were monitored for ≤4 years and were the focus of predictive models. Three predictive models (1 [100 clinical variables], 2 [158 peptides], and 3 [100 clinical variables +158 peptides]) were evaluated using area under the receiver operating characteristic (AUROC) values. Clinical and protein feature patterns were evaluated by linear mixed-effect analysis within the model at 12 and 24 months among patients who did (CHR-SMI-T) and did not transition (CHR-SMI-NT) and the entire group. RESULT: Eighteen CHR-SMI individuals with major psychiatric disorders (first episode psychosis: 2; bipolar II disorder: 13; major depressive disorder; 3) developed disorders over an average of 17.7 months. The combined model showed the highest discriminatory performance (AUROC = 0.73). Cytosolic malate dehydrogenase and transgelin-2 levels were lower in the CHR-SMI-T than the CHR-SMI-NT group. Complement component C9, inter-alpha-trypsin inhibitor heavy chain H4, von Willebrand factor, and C-reactive protein were lower in the patient than the CHR-SMI-NT group. These differences were non-significant after FDR adjustment. LIMITATIONS: Small sample, no control for medication use. CONCLUSION: This exploratory study identified clinical and proteomic markers that might predict severe mental illness early onset, which could aid in early detection and intervention. Future studies with larger samples and controlled variables are needed to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
- Proteomics Core Facility, Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea; Transdisciplinary Department of Medicine & Advanced Technology, Seoul National University Hospital,…
- Department of Psychiatry, Seoul St. Mary's Hospital, Seoul, Republic of Korea.
- Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Neuropsychiatry, Kosin University Gospel Hospital, Busan, Republic of Korea.
- Mental Health Center, Seoul National University Health Care Center, Seoul, Republic of Korea; Department of Human Systems Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Förderung
- Korea Ministry of Science and ICT
- Ministry of Health and Welfare
Zitieren
APA
Lee, H., Han, D., Rhee, S. J., Lee, J., Kim, J., Lee, Y., Kim, E. Y., Park, D. Y., Roh, S., Baik, M., Jung, H. Y., Lee, T. Y., Kim, M., Kim, H., Kim, S. H., Kwon, J. S., Ahn, Y. M., & Ha, K. (2025). Identifying clinical and proteomic markers for early diagnosis and prognosis prediction of major psychiatric disorders. Journal of Affective Disorders, 369, 886-896. https://doi.org/10.1016/j.jad.2024.10.054
Vancouver
Lee H, Han D, Rhee SJ, Lee J, Kim J, Lee Y, et al. Identifying clinical and proteomic markers for early diagnosis and prognosis prediction of major psychiatric disorders. Journal of Affective Disorders. 2025;369:886-896. doi:10.1016/j.jad.2024.10.054
BibTeX
@article{Lee2025,
author = {Lee, Hyunju and Han, Dohyun and Rhee, Sang Jin and Lee, Junhee and Kim, Jayoun and Lee, Yunna and Kim, Eun Young and Park, Dong Yeon and Roh, Sungwon and Baik, Myungjae and Jung, Hee Yeon and Lee, Tae Young and Kim, Minah and Kim, Hyeyoon and Kim, Se Hyun and Kwon, Jun Soo and Ahn, Yong Min and Ha, Kyooseob},
title = {Identifying clinical and proteomic markers for early diagnosis and prognosis prediction of major psychiatric disorders},
journal = {Journal of Affective Disorders},
year = {2025},
volume = {369},
pages = {886--896},
doi = {10.1016/j.jad.2024.10.054}
}
EUVIMED